NasdaqCM - Nasdaq Real Time Price • USD
BeyondSpring Inc. (BYSI)
As of 10:59 AM EDT. Market Open.
Earnings Estimate
CURRENCY IN USD | Current Qtr. (Mar 2022) | Next Qtr. (Jun 2022) | Current Year (2022) | Next Year (2023) |
---|---|---|---|---|
No. of Analysts | -- | -- | -- | 1 |
Avg. Estimate | 0 | 0 | 0 | -0.47 |
Low Estimate | 0 | 0 | 0 | -0.47 |
High Estimate | 0 | 0 | 0 | -0.47 |
Year Ago EPS | -0.44 | -0.49 | -- | -- |
Revenue Estimate
CURRENCY IN USD | Current Qtr. (Mar 2022) | Next Qtr. (Jun 2022) | Current Year (2022) | Next Year (2023) |
---|---|---|---|---|
No. of Analysts | 1 | 1 | 2 | 1 |
Avg. Estimate | 30M | 340k | 1.35M | 1.4M |
Low Estimate | 30M | 340k | -- | 1.4M |
High Estimate | 30M | 340k | 31.01M | 1.4M |
Year Ago Sales | 338k | 338k | 1.35M | 1.35M |
Sales Growth (year/est) | 8,775.70% | 0.60% | 0.00% | 3.60% |
Earnings History
CURRENCY IN USD | 3/31/2021 | 6/30/2021 | 9/30/2021 | 12/31/2021 |
---|---|---|---|---|
EPS Est. | -0.54 | -0.33 | -0.37 | -0.26 |
EPS Actual | -0.44 | -0.49 | -0.47 | -0.24 |
Difference | 0.1 | -0.16 | -0.1 | 0.02 |
Surprise % | 18.50% | -48.50% | -27.00% | 7.70% |
EPS Trend
CURRENCY IN USD | Current Qtr. (Mar 2022) | Next Qtr. (Jun 2022) | Current Year (2022) | Next Year (2023) |
---|---|---|---|---|
Current Estimate | 0 | 0 | 0 | -0.47 |
7 Days Ago | 0.48 | -0.34 | -1.13 | -0.47 |
30 Days Ago | 0.48 | -0.34 | -1.13 | -0.47 |
60 Days Ago | 0.48 | -0.34 | -1.13 | -0.47 |
90 Days Ago | 0.48 | -0.34 | -1.13 | -0.47 |
EPS Revisions
CURRENCY IN USD | Current Qtr. (Mar 2022) | Next Qtr. (Jun 2022) | Current Year (2022) | Next Year (2023) |
---|---|---|---|---|
Up Last 7 Days | -- | -- | -- | -- |
Up Last 30 Days | -- | -- | -- | -- |
Down Last 7 Days | -- | -- | -- | -- |
Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
CURRENCY IN USD | BYSI | Industry | Sector | S&P 500 |
---|---|---|---|---|
Current Qtr. | -- | -- | -- | 1.50% |
Next Qtr. | -- | -- | -- | 11.40% |
Current Year | -- | -- | -- | 5.20% |
Next Year | -- | -- | -- | 13.40% |
Next 5 Years (per annum) | -159.60% | -- | -- | 11.09% |
Past 5 Years (per annum) | -- | -- | -- | -- |
Research Analysis
Upgrades & Downgrades
Maintains | Baird: Outperform | 5/2/2023 |
Downgrade | Jefferies: Buy to Hold | 12/2/2021 |
Downgrade | B of A Securities: Buy to Underperform | 12/2/2021 |
Downgrade | HC Wainwright & Co.: Buy to Neutral | 12/1/2021 |
Maintains | HC Wainwright & Co.: Buy | 9/20/2021 |
Initiated | Baird: Outperform | 9/9/2021 |
Related Tickers
PSTV Plus Therapeutics, Inc.
1.5900
-0.61%
BIVI BioVie Inc.
0.4900
-3.05%
XTLB XTL Biopharmaceuticals Ltd.
2.4187
-5.52%
KTTA Pasithea Therapeutics Corp.
7.24
+3.43%
AUPH Aurinia Pharmaceuticals Inc.
4.7850
-4.87%
QNRX Quoin Pharmaceuticals, Ltd.
0.6350
-1.17%
ALLO Allogene Therapeutics, Inc.
2.8650
-5.76%
BTAI BioXcel Therapeutics, Inc.
2.5900
-4.43%
BCAB BioAtla, Inc.
2.3250
-1.06%
NKTR Nektar Therapeutics
1.3550
-1.81%